GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $11,950,000 | +2.1% | 279,553 | +9.9% | 0.21% | -2.3% |
| Q3 2014 | $11,701,000 | -9.7% | 254,437 | +5.1% | 0.22% | -6.9% |
| Q2 2014 | $12,954,000 | +28.8% | 242,186 | +28.7% | 0.23% | +20.8% |
| Q1 2014 | $10,057,000 | -25.1% | 188,194 | -25.2% | 0.19% | -12.7% |
| Q4 2013 | $13,428,000 | +16.5% | 251,541 | +9.5% | 0.22% | +0.5% |
| Q3 2013 | $11,526,000 | +49.9% | 229,693 | +49.2% | 0.22% | +32.7% |
| Q2 2013 | $7,691,000 | – | 153,956 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |